AMGN34:BVMF
Amgen Inc. BDR
93,16 BRL
0,00%
(0,00) 1 D
10. nov., 17:45:16 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for AMGN34 …
Åpne
92,46 BRL
Høy
93,16 BRL
Lav
92,38 BRL
Markedsverdi
251,65 mrd.
Snittvolum
318,00
Volum
6,00
52 u høy
94,72 BRL
52 u lav
47,76 BRL
Utestående aksjer
540,91 mill.
Antall ansatte
32k
Åpne
92,46 BRL
Høy
93,16 BRL
Lav
92,38 BRL
Markedsverdi
251,65 mrd.
Snittvolum
318,00
Volum
6,00
52 u høy
94,72 BRL
52 u lav
47,76 BRL
Utestående aksjer
540,91 mill.
Antall ansatte
32k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Yahoo Finance
·
for 1 time siden
iShares Biotechnology ETF (IBB) Adds Gilead and Amgen on Nov. 9
Trefis
·
for 1 time siden
Is Amgen Stock Too Dependent On Six Growth Drivers?
Yahoo Finance
·
for 18 timer siden
Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
Investing.com Canada
·
for 1 døgn siden
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Om Amgen Inc. BDR
Administrerende direktørRobert A. Bradway
Ansatte31,5k
Grunnlagt1980
HovedkontorThousand Oaks, California, USA
SektorHealth Care
Bransje-
Nettstedamgen.com